Proliferation of primary human hepatocytes and prevention of hepatitis B virus reinfection efficiently deplete nuclear cccDNA in vivo

Objective The stability of the covalently closed circular DNA (cccDNA) in nuclei of non-dividing hepatocytes represents a key determinant of HBV persistence. Contrarily, studies with animal hepadnaviruses indicated that hepatocyte turnover can reduce cccDNA loads but knowledge on the proliferative capacity of HBV-infected primary human hepatocytes (PHHs) in vivo and the fate of cccDNA in dividing PHHs is still lacking. This study aimed to determine the impact of human hepatocyte division on cccDNA stability in vivo. Methods PHH proliferation was triggered by serially transplanting hepatocytes from HBV-infected humanised mice into naïve recipients. Cell proliferation and virological changes were assessed by quantitative PCR, immunofluorescence and RNA in situ hybridisation. Viral integrations were analysed by gel separation and deep sequencing. Results PHH proliferation strongly reduced all infection markers, including cccDNA (median 2.4 log/PHH). Remarkably, cell division appeared to cause cccDNA dilution among daughter cells and intrahepatic cccDNA loss. Nevertheless, HBV survived in sporadic non-proliferating human hepatocytes, so that virological markers rebounded as hepatocyte expansion relented. This was due to reinfection of quiescent PHHs since treatment with the entry inhibitor myrcludex-B or nucleoside analogues blocked viral spread and intrahepatic cccDNA accumulation. Viral integrations were detected both in donors and recipient mice but did not appear to contribute to antigen production. Conclusions We demonstrate that human hepatocyte division even without involvement of cytolytic mechanisms triggers substantial cccDNA loss. This process may be fundamental to resolve self-limiting acute infection and should be considered in future therapeutic interventions along with entry inhibition strategies.

[1]  M. Manns,et al.  Viral and Host Responses After Stopping Long-term Nucleos(t)ide Analogue Therapy in HBeAg-Negative Chronic Hepatitis B. , 2016, The Journal of infectious diseases.

[2]  Xuan Wang,et al.  Asymmetric partitioning of transfected DNA during mammalian cell division , 2016, Proceedings of the National Academy of Sciences.

[3]  U. Protzer,et al.  Attacking hepatitis B virus cccDNA--The holy grail to hepatitis B cure. , 2016, Journal of hepatology.

[4]  M. Heikenwalder,et al.  Interferon-γ and Tumor Necrosis Factor-α Produced by T Cells Reduce the HBV Persistence Form, cccDNA, Without Cytolysis. , 2016, Gastroenterology.

[5]  B. McMahon,et al.  Present and future therapies of hepatitis B: From discovery to cure , 2015, Hepatology.

[6]  L. Calvo,et al.  IL6 Inhibits HBV Transcription by Targeting the Epigenetic Control of the Nuclear cccDNA Minichromosome , 2015, PloS one.

[7]  G. Raimondo,et al.  Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma , 2015, Liver international : official journal of the International Association for the Study of the Liver.

[8]  A. Lohse,et al.  Hepatitis Delta co-infection in humanized mice leads to pronounced induction of innate immune responses in comparison to HBV mono-infection. , 2015, Journal of hepatology.

[9]  Y. Liaw,et al.  Systematic review: cessation of long‐term nucleos(t)ide analogue therapy in patients with hepatitis B e antigen‐negative chronic hepatitis B , 2015, Alimentary pharmacology & therapeutics.

[10]  M. Nassal HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B , 2015, Gut.

[11]  M. Muramatsu,et al.  TGF-β Suppression of HBV RNA through AID-Dependent Recruitment of an RNA Exosome Complex , 2015, PLoS pathogens.

[12]  B. Autran,et al.  Towards an HBV cure: state-of-the-art and unresolved questions—report of the ANRS workshop on HBV cure , 2015, Gut.

[13]  A. Bertoletti,et al.  Immunotherapy of HCC metastases with autologous T cell receptor redirected T cells, targeting HBsAg in a liver transplant patient. , 2015, Journal of hepatology.

[14]  A. Bertoletti,et al.  Circumventing failed antiviral immunity in chronic hepatitis B virus infection: triggering virus-specific or innate-like T cell response? , 2014, Medical Microbiology and Immunology.

[15]  Hoang Hai,et al.  Role of hepatitis B virus DNA integration in human hepatocarcinogenesis. , 2014, World journal of gastroenterology.

[16]  T. Liang,et al.  Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA , 2014, Science.

[17]  A. Lohse,et al.  Immune cell responses are not required to induce substantial hepatitis B virus antigen decline during pegylated interferon-alpha administration. , 2014, Journal of hepatology.

[18]  S. Litwin,et al.  Duck hepatitis B virus covalently closed circular DNA appears to survive hepatocyte mitosis in the growing liver. , 2013, Virology.

[19]  A. Lohse,et al.  The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus. , 2013, Journal of hepatology.

[20]  Y. Liaw Impact of therapy on the outcome of chronic hepatitis B , 2013, Liver international : official journal of the International Association for the Study of the Liver.

[21]  D. Vassilopoulos,et al.  Sustained responses and loss of HBsAg in HBeAg-negative patients with chronic hepatitis B who stop long-term treatment with adefovir. , 2012, Gastroenterology.

[22]  M. Buendia,et al.  Diverse roles of hepatitis B virus in liver cancer. , 2012, Current opinion in virology.

[23]  M. Dandri,et al.  New insight in the pathobiology of hepatitis B virus infection , 2012, Gut.

[24]  M. Levrero,et al.  IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome. , 2012, The Journal of clinical investigation.

[25]  A. Bertoletti,et al.  Republished: Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection , 2011, Postgraduate Medical Journal.

[26]  H. Blum,et al.  Generation of Covalently Closed Circular DNA of Hepatitis B Viruses via Intracellular Recycling Is Regulated in a Virus Specific Manner , 2010, PLoS pathogens.

[27]  E. Fuchs,et al.  In vivo proliferation of hepadnavirus‐infected hepatocytes induces loss of covalently closed circular DNA in mice , 2010, Hepatology.

[28]  S. Litwin,et al.  Clonal Expansion of Normal-Appearing Human Hepatocytes during Chronic Hepatitis B Virus Infection , 2010, Journal of Virology.

[29]  Y. Ni,et al.  Fine Mapping of Pre-S Sequence Requirements for Hepatitis B Virus Large Envelope Protein-Mediated Receptor Interaction , 2009, Journal of Virology.

[30]  Hildegard Büning,et al.  Not interferon, but interleukin‐6 controls early gene expression in hepatitis B virus infection , 2009, Hepatology.

[31]  M. Levrero,et al.  Control of cccDNA function in hepatitis B virus infection. , 2009, Journal of hepatology.

[32]  S. Litwin,et al.  Detection of Clonally Expanded Hepatocytes in Chimpanzees with Chronic Hepatitis B Virus Infection , 2008, Journal of Virology.

[33]  F. Zoulim,et al.  Persistence of the hepatitis B virus covalently closed circular DNA in HepaRG human hepatocyte-like cells. , 2009, The Journal of general virology.

[34]  M. Nassal Hepatitis B viruses: reverse transcription a different way. , 2008, Virus research.

[35]  U. Haberkorn,et al.  Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein , 2008, Nature Biotechnology.

[36]  S. Litwin,et al.  Hepatocyte turnover in transient and chronic hepadnavirus infections , 2007, Journal of viral hepatitis.

[37]  P. Caini,et al.  Modifications of plasma platelet‐activating factor (PAF)‐acetylhydrolase/PAF system activity in patients with chronic hepatitis C virus infection , 2007, Journal of viral hepatitis.

[38]  P. Schirmacher,et al.  Peginterferon alpha‐2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B , 2006, Hepatology.

[39]  Junn-Liang Chang,et al.  Blocking of G1/S transition and cell death in the regenerating liver of Hepatitis B virus X protein transgenic mice. , 2006, Biochemical and biophysical research communications.

[40]  T. Okanoue,et al.  Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas , 2005, Gut.

[41]  J. Summers,et al.  Clonal expansion of hepatocytes during chronic woodchuck hepatitis virus infection. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[42]  C. Gibbs,et al.  Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. , 2004, Gastroenterology.

[43]  S. Litwin,et al.  INAUGURAL ARTICLES: Hepatocyte turnover during resolution of a transient hepadnaviral infection , 2003 .

[44]  R. Purcell,et al.  CD8+ T Cells Mediate Viral Clearance and Disease Pathogenesis during Acute Hepatitis B Virus Infection , 2003, Journal of Virology.

[45]  R. McCuskey,et al.  Kupffer cells participate in early clearance of syngeneic hepatocytes transplanted in the rat liver. , 2002, Gastroenterology.

[46]  Half-Life of the Duck Hepatitis B Virus Covalently Closed Circular DNA Pool In Vivo following Inhibition of Viral Replication , 2002, Journal of Virology.

[47]  Alexander Bürkle,et al.  Increase in de novo HBV DNA integrations in response to oxidative DNA damage or inhibition of poly(ADP‐ribosyl)ation , 2002, Hepatology.

[48]  R. Purcell,et al.  CD 8 T Cells Mediate Viral Clearance and Disease Pathogenesis during Acute Hepatitis B Virus Infection † , 2002 .

[49]  C. Rogler,et al.  Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus , 2001, Hepatology.

[50]  M. I. Barrasa,et al.  Apoptosis and Regeneration of Hepatocytes during Recovery from Transient Hepadnavirus Infections , 2000, Journal of Virology.

[51]  M. Shapiro,et al.  Viral clearance without destruction of infected cells during acute HBV infection. , 1999, Science.

[52]  H. O'brodovich,et al.  Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transfer , 1999, Gene Therapy.

[53]  W. Mason,et al.  Lack of effect of antiviral therapy in nondividing hepatocyte cultures on the closed circular DNA of woodchuck hepatitis virus , 1997, Journal of virology.

[54]  F. Chisari Cytotoxic T cells and viral hepatitis. , 1997, The Journal of clinical investigation.

[55]  C. Bréchot,et al.  A novel PCR technique using Alu-specific primers to identify unknown flanking sequences from the human genome. , 1995, Genomics.